"We are absolutely not recommending metformin for our breast cancer patients for the purposes of preventing breast cancer," Burstein said. Action Points In patients with diabetes and HER2-positive breast cancer, metformin improved outcomes, but benefits were limited to patients who also had hormone receptor-positive breast cancer. Metformin has again been found to improve outcomes in breast cancer, in this case early HER2-positive breast cancer but the benefits observed in disease-free and overall survival were limited to patients who also had hormone receptor-positive breast cancer, researchers said. "This is the first analysis from a prospective trial that demonstrates the benefit from metformin treatment in patients with diabetes and HER2-positive breast cancer," Sonnenblick and colleagues emphasized. Asked to facebook/" target="_blank">comment on the study, Harold Burstein, MD, of Harvard Medical School in Boston and an ASCO expert in breast cancer, pointed out that findings fits with a theme that has been building over the past few years about how metabolism and inflammation and glucose regulation might affect breast cancer outcomes.
The American Cancer Society estimates 41,070 women will die of breast cancer in the United States this year. After nearly losing his mother to breast cancer, a Mexican teen decided to invent something to help women detect the disease during its early stages. On Saturday, the breast cancer detection bra won the top prize at the Global Student Entrepreneur Awards finals competition, which hosted 56 student entrepreneurs from 56 countries. "What happens is we take all that data and store it," Ríos Cantú said in an interview with El Universal. Ríos Cantú is currently the CEO and co-founder of Higia Technologies, a company he established with three close friends when he was 17.
collected by :Lucy William
No comments:
Post a Comment